Skip to Main Content

Paper Details

AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.
Clin Cancer Res
41
2017
AZ1366, EGFR, EGFR-dependent NSCLC, EGFR-driven, EGFR-driven NSCLC, EGFR-driven cancers, EGFR-driven tumors, NSCLC, NSCLC lines, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Cells, Tankyrase, Wnt, erlotinib, gefitinib, mice, mouse, non-small cell lung cancer, orthotopic tumors, osimertinib, patients, tankyrase, tumor
Author NameAffiliation
Aik Choon TanUniversity of Colorado Anschutz Medical Campus (AMC)
Aik Choon TanUniversity of Colorado Anschutz Medical Campus (AMC)
Vadym Zaberezhnyy
James DeGregori
  • 1 - 4

Datasets

Release 1.2